In the 2021 WHO classification of tumors of the central nervous system, glioblastoma is defined by the absence of a mutation in the isocitrate dehydrogenase gene (i.e., IDH wildtype) [14]. The gene discussed is IDH2; the disease is central nervous system cancer.